2-氟-5-甲酰苯硼酸 | 352534-79-3

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氟-5-甲酰苯硼酸
• 中文别名: 2-氟-5-甲酰基苯硼酸；2-氟-5-甲醛基苯硼酸；2-氟-5-醛基苯硼酸
• 英文名称: (2-fluoro-5-formylphenyl)boronic acid
• 英文别名: 2-fluoro-5-formylphenyl boronic acid；2-fluoro-3-formylbenzenboronic acid；2-fluoro-5-formylphenylboronic acid；(2-fluoro-5-formyl-phenyl)-boronic acid；2-fluoro-5-formylbenzeneboronic acid
• CAS: 352534-79-3
• 化学式: C₇H₆BFO₃
• mdl: MFCD03095100
• 分子量: 167.932
• InChiKey: SQSWYWCEKCVQEA-UHFFFAOYSA-N

物化性质

• 熔点：
  168-171°C
• 稳定性/保质期：
  避免与氧化物和空气接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.45
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• 海关编码：
  2931900090
• 安全说明：
  S22,S26,S36/37/39
• 危险性防范说明：
  P233,P260,P261,P264,P271,P280,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
• 危险性描述：
  H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
2-Fluoro-5-formylphenylboronic acid
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
2-Fluoro-5-formylphenylboronic acid
Ingredient name:
CAS number: 352534-79-3

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H6BFO3
Molecular weight: 167.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氟-5-甲酰苯硼酸 在 二氟化氢钾 作用下， 以 甲醇 为溶剂， 生成 三氟(2-氟-5-甲酰基苯基)硼酸钾
  参考文献：
  名称：

  负变构调节剂在CXC-基序趋化因子受体CXCR3上产生的偏倚和探针依赖性信号传导的分子机制。

  摘要：

  我们最近对具有改进性能的变构调节剂的探索导致鉴定了两个有偏向的负变构调节剂BD103（N-1-{[3-（4-乙氧基苯基）-4-oxo-3,4-二氢吡啶并[2,3- d]嘧啶-二乙烯基]乙基} -4-（4-氟丁氧基）-N-[（1-甲基哌啶-4-基）甲基}]丁酰胺）和BD064（5-[（N- {1- [3-（ 4-乙氧基苯基）-4-氧代-3,4-二氢吡啶并[2,3-d]嘧啶-2-基]乙基-2- [4-氟-3-（三氟甲基）苯基]乙酰胺基）甲基] -2-氟苯基}硼酸），表现出对CXC-基序趋化因子受体CXCR3信号的探针依赖性抑制。为了阐明其选择性和探针依赖性的结构机理，我们使用了定点诱变与同源性建模和对接相结合，以鉴定有助于调节剂结合，信号转导的CXCR3氨基酸，和合作的传递。使用变构放射性配体RAMX3（[3H] N- {1- [3-（4-乙氧基苯基）-4-氧代-3,4-二氢吡啶基[2,3-d]嘧啶-2-基]乙基}-

  DOI：

  10.1124/mol.117.110296
• 作为产物：
  描述：

  三氟(2-氟-5-甲酰基苯基)硼酸钾 、 水 在 montmorillonite K₁₀ 作用下， 反应 24.0h， 以90%的产率得到2-氟-5-甲酰苯硼酸
  参考文献：
  名称：

  An Efficient Method for the Hydrolysis of Potassium Organotrifluoroborates Promoted by Montmorillonite K10

  摘要：

  An efficient and non-expensive method for conversion of diverse potassium organotrifluoroborates to their corresponding boronic acids promoted by montmorillonite K10 using water as the reaction solvent is described. Further interconversion of potassium organotrifluoroborates to their corresponding boronic esters, via boronic acid intermediates was also successfully accomplished. The products were obtained in good yields, being the rate of hydrolysis influenced by the type of substituent present in the boronic acid.

  DOI：

  10.21577/0103-5053.20180126

文献信息

• Redox-Neutral Photocatalytic Cyclopropanation via Radical/Polar Crossover
  作者：James P. Phelan、Simon B. Lang、Jordan S. Compton、Christopher B. Kelly、Ryan Dykstra、Osvaldo Gutierrez、Gary A. Molander

  DOI：10.1021/jacs.8b05243

  日期：2018.6.27

  A benchtop stable, bifunctional reagent for the redox-neutral cyclopropanation of olefins has been developed. Triethylammonium bis(catecholato)iodomethylsilicate can be readily prepared on multigram scale. Using this reagent in combination with an organic photocatalyst and visible light, cyclopropanation of an array of olefins, including trifluoromethyl- and pinacolatoboryl-substituted alkenes, can

  已开发出一种用于烯烃氧化还原中性环丙烷化的台式稳定双功能试剂。三乙基铵双（儿茶酚）碘甲基硅酸盐可以很容易地以多克规模制备。将该试剂与有机光催化剂和可见光结合使用，可以在数小时内完成一系列烯烃（包括三氟甲基和频哪醇硼基取代的烯烃）的环丙烷化反应。该反应对传统的反应性官能团（羧酸、碱性杂环、卤代烷等）具有高度耐受性，并允许聚烯烃化合物的化学选择性环丙烷化。机理研究表明，反应通过快速阴离子 3-exotet 环闭合进行，该途径与实验和计算数据一致。
• [EN] INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING<br/>[FR] INHIBITEURS DE LA LIAISON ENTRE LA PROTÉINE WDR5 ET SES PARTENAIRES DE LIAISON
  申请人：ONTARIO INST FOR CANCER RES (OICR)

  公开号：WO2017147701A1

  公开（公告）日：2017-09-08

  The present application is directed to compounds of Formula I: (I) compositions comprising these compounds and their uses, for example as medicaments for the treatment of diseases, disorders or conditions mediated or treatable by inhibition of binding between WDR5 protein and its binding partners.

  本申请涉及到Formula I的化合物：(I) 包含这些化合物的组合物及其用途，例如作为治疗由于抑制WDR5蛋白与其结合伙伴之间结合而介导或可治疗的疾病、紊乱或状况的药物。
• POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
  申请人：DE PERETTI Danielle

  公开号：US20110065699A1

  公开（公告）日：2011-03-17

  Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 and X are as defined in the disclosure, or an acid addition salt thereof, and the therapeutic use and process of synthesis thereof.

  式（I）的化合物： 其中R1、R2、R3、R4和X如披露中所定义，或其酸盐加合物，以及其治疗用途和合成过程。
• [EN] FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS THIAZOLE ET THIOPHÈNE FUSIONNÉS COMME INHIBITEURS DE KINASE
  申请人：UCB PHARMA SA

  公开号：WO2009071895A1

  公开（公告）日：2009-06-11

  A series of fused bicyclic thiazole and thiophene derivatives which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, and in the 4-position by hydroxy, oxo or an amine moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. (I)

  一系列在2位被一个可选择取代的吗啡啉-4-基团取代，并在4位被羟基、酮基或胺基团取代的融合双环噻唑和噻吩衍生物，作为选择性PI3激酶酶抑制剂，在医学上具有益处，例如在治疗炎症、自身免疫、心血管、神经退行性、代谢、肿瘤、疼痛或眼科疾病方面。（I）
• Kinase inhibitors and methods of their use
  申请人：BURGER Matthew T.

  公开号：US20100056576A1

  公开（公告）日：2010-03-04

  New compounds, compositions and methods of inhibition of Provirus Integration of Maloney Kinase (PIM kinase) activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one PIM kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase-mediated disorder, such as cancer.

  提供了一种新的化合物、组合物和抑制与人类或动物宿主肿瘤发生相关的莫洛尼激酶（PIM激酶）活性的方法。在某些实施例中，该化合物和组合物能有效抑制至少一种PIM激酶的活性。这些新的化合物和组合物可以单独使用，也可以与至少一种其他试剂联合使用，用于治疗由丝氨酸/苏氨酸激酶或受体酪氨酸激酶介导的疾病，如癌症。